Nolvadex (Tamoxifen Citrate)
Tamoxifencitrate
ProductName:Nolvadex(TamoxifenCitrate)
CAS:54965-24-1
Purity:99%
Appearance:whitecrystallinepowder
EINECSNo.:234-118-0
- 32H37NO8
Lossondrying:NMT0.5%
Residueonignition:NMT0.2%
Iron:NMT0.005%
Heavymetals:NMT0.001%
E-isomer:NMT0.3%
Conclusion:ConformswithstandardUSP36
Pleasecontacttinathroughtinaatbioprocodotcom.
在线联系供应商
Other supplier products
 |
Turinabol powder | OralTurinabol ProductName:Oralturinabol(4-Chlorodehydromethyltestosterone) CAS:2446-23-3 Purity:99% Appearance:whitecrystallinepowder EINECSNo... |
 |
Yohimbine Hydrochloride | YohimbineHydrochloride CASNo.:65-19-0 Purity:99% Appearance:whitecrystallinepowder Solubility:solubleinchloroform,solubleinmethanol,ethanol,slightl... |
 |
Clomid (Clomiphene Citrate) | ClomifeneCitrate Clomid(ClomipheneCitrate) CAS:50-41-9 Purity:99% Appearance:whitepowder EINECSNo.:200-035-3 32H36ClNO8 Specifications: Appearan... |
 |
Boldenone Undecylenate (Equipoise, EQ) | BoldenoneUndecylenate(Equipoise,EQ) CAS:13103-34-9 Purity:98% Appearance:slightlyyellowoilyliquid EINECSNo.:236-024-5 30H44O3 Solubility:almosti... |
 |
Melanotan II | MelanotanII ProductName:MelanotanII(MT2),Melanotan2,MT-2,MT-II MolecularFormula:C50H69N15O9 MolecularWeight:1024.20 Appearance:Whitetooffwhitepowde... |
Same products
 |
浙江东杰冷却塔有限公司 | 卖方: 浙江东杰冷却塔有限公司 | 轻质高强比是钢材的20-50倍。设计中采用刚度指标控制框架结构，提供足够的承载能力，提高结构在突发极限载荷作用下的安全性。 |
 |
glass beads for road marking | 卖方: Langfang Olan Glass Beads Co.,Ltd | Reflective glass beads can improve the retro-reflection property of the road marking line. Drivin... |
 |
MONSA® BTMS | 卖方: Guangzhou Monsa Chemical Co., Ltd | INCI name: Behentrimonium Methosulfate MONSA® BTMS is a behenyl (C22) cationic quaternary ... |
 |
MONSA® BT-85 | 卖方: Guangzhou Monsa Chemical Co., Ltd | INCI name: Behentrimonium Chloride BT-85 is a quaternary ammonium salt that is mainly used as ... |
 |
MONSA® BKC-80 | 卖方: Guangzhou Monsa Chemical Co., Ltd | INCI name: Benzalkonium Chloride / alkyldimethylbenzylammonium chloride Benzalkonium chloride ... |
